3-nitropropionic acid has been researched along with Mitochondrial Diseases in 8 studies
3-nitropropionic acid: succinate dehydrogenase inactivator; biosynthesized by FABACEAE plants from ASPARAGINE
3-nitropropanoic acid : A C-nitro compound that is propanoic acid in which one of the methyl hydrogens has been replaced by a nitro group.
Mitochondrial Diseases: Diseases caused by abnormal function of the MITOCHONDRIA. They may be caused by mutations, acquired or inherited, in mitochondrial DNA or in nuclear genes that code for mitochondrial components. They may also be the result of acquired mitochondria dysfunction due to adverse effects of drugs, infections, or other environmental causes.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (50.00) | 29.6817 |
| 2010's | 4 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mendoza, E | 1 |
| Miranda-Barrientos, JA | 1 |
| Vázquez-Roque, RA | 1 |
| Morales-Herrera, E | 1 |
| Ruelas, A | 1 |
| De la Rosa, G | 1 |
| Flores, G | 1 |
| Hernández-Echeagaray, E | 1 |
| Mehrotra, A | 1 |
| Kanwal, A | 1 |
| Banerjee, SK | 1 |
| Sandhir, R | 1 |
| Thangarajan, S | 1 |
| Ramachandran, S | 1 |
| Krishnamurthy, P | 1 |
| Zou, J | 1 |
| Zhang, Y | 1 |
| Yin, S | 1 |
| Wu, H | 1 |
| Pyykkö, I | 1 |
| Fujinami, Y | 1 |
| Mutai, H | 1 |
| Kamiya, K | 1 |
| Mizutari, K | 1 |
| Fujii, M | 1 |
| Matsunaga, T | 1 |
| Pérez-De La Cruz, V | 1 |
| González-Cortés, C | 1 |
| Pedraza-Chaverrí, J | 1 |
| Maldonado, PD | 1 |
| Andrés-Martínez, L | 1 |
| Santamaría, A | 1 |
| Escartin, C | 1 |
| Boyer, F | 1 |
| Bemelmans, AP | 1 |
| Hantraye, P | 1 |
| Brouillet, E | 1 |
| Kwak, S | 1 |
1 review available for 3-nitropropionic acid and Mitochondrial Diseases
| Article | Year |
|---|---|
[Huntington disease].
Topics: Animals; Corpus Striatum; Diagnosis, Differential; Humans; Huntingtin Protein; Huntington Disease; M | 2002 |
7 other studies available for 3-nitropropionic acid and Mitochondrial Diseases
| Article | Year |
|---|---|
In vivo mitochondrial inhibition alters corticostriatal synaptic function and the modulatory effects of neurotrophins.
Topics: Animals; Brain-Derived Neurotrophic Factor; Cerebral Cortex; Corpus Striatum; Glutamic Acid; Male; M | 2014 |
Mitochondrial modulators in experimental Huntington's disease: reversal of mitochondrial dysfunctions and cognitive deficits.
Topics: Acetylcarnitine; Animals; Cognition Disorders; Drug Therapy, Combination; Female; Huntington Disease | 2015 |
Chrysin exerts neuroprotective effects against 3-Nitropropionic acid induced behavioral despair-Mitochondrial dysfunction and striatal apoptosis via upregulating Bcl-2 gene and downregulating Bax-Bad genes in male wistar rats.
Topics: Animals; Apoptosis; Basal Ganglia; bcl-2-Associated X Protein; bcl-Associated Death Protein; Behavio | 2016 |
Mitochondrial dysfunction disrupts trafficking of Kir4.1 in spiral ganglion satellite cells.
Topics: Acoustic Stimulation; Animals; Electroencephalography; Evoked Potentials, Auditory, Brain Stem; Fema | 2009 |
Enhanced expression of C/EBP homologous protein (CHOP) precedes degeneration of fibrocytes in the lateral wall after acute cochlear mitochondrial dysfunction induced by 3-nitropropionic acid.
Topics: Activating Transcription Factor 4; Acute Disease; Animals; Apoptosis; Hearing Loss, Sensorineural; I | 2010 |
Protective effect of S-allylcysteine on 3-nitropropionic acid-induced lipid peroxidation and mitochondrial dysfunction in rat brain synaptosomes.
Topics: Animals; Brain; Cysteine; Dose-Response Relationship, Drug; Drug Interactions; Lipid Peroxidation; M | 2006 |
IGF-1 exacerbates the neurotoxicity of the mitochondrial inhibitor 3NP in rats.
Topics: Animals; Cell Death; Cell Survival; Convulsants; Corpus Striatum; Disease Models, Animal; Dose-Respo | 2007 |